Topic

Pennsylvania

A collection of 524 issues

How to Get Upstaza (Eladocagene Exuparvovec) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Guide with Forms and Appeal Scripts

Quick Answer: Blue Cross Blue Shield plans in Pennsylvania require prior authorization for Upstaza (eladocagene exuparvovec) with strict documentation requirements. You'll need confirmed AADC deficiency diagnosis, failed standard therapies, and treatment at a certified gene therapy center. Start by gathering genetic test results and contacting your BCBS plan&

Renewing Blenrep (Belantamab Mafodotin) Approval with UnitedHealthcare in Pennsylvania: Timeline, Documents & Appeal Process

Quick Answer: Blenrep Renewal with UnitedHealthcare in Pennsylvania Current Status: Blenrep (belantamab mafodotin) was withdrawn from the U.S. market in 2022 and is only available through clinical trials or expanded access programs. UnitedHealthcare typically denies coverage outside these settings. For trial-related bridge therapy or expanded access, submit prior authorization

How to Get Tavalisse (Fostamatinib) Covered by Aetna CVS Health in Pennsylvania: Prior Authorization, Appeals & Cost Assistance

Quick Answer: Getting Tavalisse Covered by Aetna CVS Health in Pennsylvania Aetna requires prior authorization for Tavalisse (fostamatinib) in Pennsylvania. You'll need documented failure of corticosteroids and at least one thrombopoietin receptor agonist, plus a hematologist's prescription. First step today: Have your hematologist submit a PA

How to Get Kineret (anakinra) Covered by Aetna in Pennsylvania: PA Requirements, Appeals, and Cost Assistance

Quick Answer: Getting Kineret (anakinra) Covered by Aetna in Pennsylvania Kineret requires prior authorization from Aetna and is subject to step therapy requirements. You'll typically need documented failure or intolerance of at least one conventional DMARD and one biologic DMARD first. The medication must be filled through CVS

Lowering Out-of-Pocket Costs for Jynarque (Tolvaptan) with UnitedHealthcare in Pennsylvania: Complete Copay and Appeals Guide

Answer Box: Getting Jynarque Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Jynarque (tolvaptan) but has no step therapy requirement. Commercially insured patients can access Otsuka's copay program for as little as $10/month (up to $8,000 annually). If denied, Pennsylvania's new external

How to Get Tavneos (Avacopan) Covered by Cigna in Pennsylvania: Complete PA Guide with Appeals Process

Answer Box: Getting Tavneos (Avacopan) Covered by Cigna in Pennsylvania Tavneos requires prior authorization from Cigna and must be prescribed by a specialist for ANCA-associated vasculitis. The fastest path to approval: (1) Ensure your rheumatologist, nephrologist, or pulmonologist completes Cigna's PA form with positive ANCA labs and combination

Complete Coding Guide: Getting Kuvan (Sapropterin) Covered by Humana in Pennsylvania - ICD-10, NDC, and Prior Authorization Requirements

Answer Box: Fastest Path to Kuvan Coverage with Humana in Pennsylvania Kuvan (sapropterin dihydrochloride) requires prior authorization from Humana Medicare Advantage plans in Pennsylvania. Submit requests using the correct NDC code (not J-codes), ICD-10 code E70.0 (classical PKU) or E70.1 (other hyperphenylalaninemias), and comprehensive documentation showing BH4 responsiveness.

How to Get Opzelura (Ruxolitinib Cream) Covered by Cigna in Pennsylvania: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Opzelura Covered by Cigna in Pennsylvania Fastest Path to Approval: Cigna requires prior authorization for Opzelura (ruxolitinib cream) with mandatory step therapy. You must document failed trials of topical corticosteroids (≥28 days) AND calcineurin inhibitors (≥12 weeks) before approval. If denied, Pennsylvania's new external review

How to Get Synagis (Palivizumab) Covered by UnitedHealthcare in Pennsylvania: Complete Appeals Guide with Templates

Quick Answer: Getting Synagis Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Synagis (palivizumab) in Pennsylvania, with strict eligibility limited to high-risk infants under 24 months. You'll need specialist documentation proving your child meets specific criteria (premature with chronic lung disease, significant congenital heart disease, or

How to Get Zanzalintinib (XL092) Covered by Humana in Pennsylvania: Complete Appeals Guide for Investigational Cancer Drugs

Quick Answer: Getting Zanzalintinib (XL092) Covered by Humana in Pennsylvania Zanzalintinib (XL092) is investigational and typically denied by Humana Medicare Advantage plans. Your fastest path: 1) Apply for Exelixis's compassionate use program (drug supplied free), 2) Submit Humana prior authorization with compassionate use approval letter, 3) If denied,